Titan Pharmaceuticals Inc (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
32 Pages - GLDATA58394
$250.00

Summary

Titan Pharmaceuticals Inc (Titan) is a biopharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. The company product portfolio offers probuphine for the treatment of opioid addiction, repinirole implant for treating Parkinson's disease and T3 implant for the treatment of hypothyroidism. It also develops product candidates for the treatment of hormonal deficiencies including type 2 diabetes, attention deficit hyperactivity disorder, benign prostate hyperplasia and others.The company also works in partnership with other companies for delivery of other compounds using ProNeura technology. Titan is headquartered in South San Francisco, California, the US.

Titan Pharmaceuticals Inc (TTNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Titan Pharmaceuticals Inc, Medical Devices Deals, 2010 to YTD 2016 9
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Braeburn Pharma Exercises Option For Licensing Agreement With Titan Pharma For Probuphine 11
Titan Pharma Amends Licensing Agreement with Braeburn Pharma for Probuphine 13
Equity Offering 15
Titan Pharma to Raise up to USD20 Million in Public Offering of Shares 15
Titan Pharma Raises USD10.5 Million in Public Offering of Units 17
Titan Pharma Raises USD5 Million in Private Placement of Shares 19
Titan Pharma Raises USD1.3 Million in Private Placement of Shares upon Exercise of Series A Warrants 20
Titan Pharma Raises USD4 Million in Private Placement of Shares upon Exercise of Series B Warrants 21
Titan Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Series B Warrants 22
Titan Pharma Completes Private Placement Of Shares For US$4 Million 23
Titan Pharma Announces Private Placement Of Shares For US$5.5 Million 24
Titan Pharma Plans Rights Offering Of Common Stock 25
Titan Pharma Files Registration Statement For Public Offering Of Securities For US$25 Million 26
Asset Transactions 27
Titan Pharma Sells Royalty Stream Of Fanapt To Deerfield Management For US$15 Million 27
Titan Pharmaceuticals Inc - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Titan Pharmaceuticals Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Titan Pharmaceuticals Inc, Medical Devices Deals, 2010 to YTD 2016 9
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Braeburn Pharma Exercises Option For Licensing Agreement With Titan Pharma For Probuphine 11
Titan Pharma Amends Licensing Agreement with Braeburn Pharma for Probuphine 13
Titan Pharma to Raise up to USD20 Million in Public Offering of Shares 15
Titan Pharma Raises USD10.5 Million in Public Offering of Units 17
Titan Pharma Raises USD5 Million in Private Placement of Shares 19
Titan Pharma Raises USD1.3 Million in Private Placement of Shares upon Exercise of Series A Warrants 20
Titan Pharma Raises USD4 Million in Private Placement of Shares upon Exercise of Series B Warrants 21
Titan Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Series B Warrants 22
Titan Pharma Completes Private Placement Of Shares For US$4 Million 23
Titan Pharma Announces Private Placement Of Shares For US$5.5 Million 24
Titan Pharma Plans Rights Offering Of Common Stock 25
Titan Pharma Files Registration Statement For Public Offering Of Securities For US$25 Million 26
Titan Pharma Sells Royalty Stream Of Fanapt To Deerfield Management For US$15 Million 27
Titan Pharmaceuticals Inc, Key Competitors 29
Titan Pharmaceuticals Inc, Key Employees 30

List of Figures
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Titan Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Titan Pharmaceuticals Inc, Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838